Prilosec Lawsuit 2019 Update: Latest Developments

Frances Aug 03, 2026

In recent years, the popular heartburn and acid reflux medication Prilosec, also known as omeprazole, has been at the center of numerous lawsuits. As of 2019, several trials and claims surrounding the drug's potential health risks have made significant progress, raising awareness among users and driving imperative changes in the pharmaceutical industry.

a woman is smiling and posing for the camera in front of a sign that says, please
a woman is smiling and posing for the camera in front of a sign that says, please

Prilosec, a proton pump inhibitor (PPI), has been linked to severe side effects such as kidney disease, bone fractures, and serious infections. The lawsuits allege that the drug's manufacturers, including AstraZeneca and Procter & Gamble, failed to adequately warn patients and doctors about these risks.

an email to someone on their phone
an email to someone on their phone

The Kidney Disease Connection

In 2019, several lawsuits focused on the link between Prilosec and kidney disease, specifically chronic interstitial nephritis (CIN). This condition results in the inflammation of kidney tissue, leading to kidney damage and potentially kidney failure.

m2
m2

Plaintiffs argue that AstraZeneca and Procter & Gamble were aware of this risk but did not provide adequate warnings, thereby prioritizing profits over patient safety.

Multidistrict Litigation

7 Different Types Of Lawsuits And How They Can Impact You
7 Different Types Of Lawsuits And How They Can Impact You

As of 2019, Prilosec kidney disease lawsuits were consolidated into a multidistrict litigation (MDL) in the U.S. District Court for the District of Minnesota. This consolidation streamlined the legal process, allowing for the efficient management of thousands of similar cases.

The MDL encompassed lawsuits from patients who developed kidney disease, CIN, and other related kidney injuries after taking Prilosec. The first bellwether trials were scheduled for early 2021, with the aim of gauging jury attitudes and determining potential settlement ranges.

Settlements and Verdicts in 2019

a woman with long blonde hair wearing a black shirt and red trim around her neck
a woman with long blonde hair wearing a black shirt and red trim around her neck

Prior to the MDL formation, several Prilosec kidney disease lawsuits were settled or resulted in verdicts. In one notable case, a jury awarded a Nevada man $237,000 after finding that AstraZeneca had failed to warn about the risks of Prilosec and kidney damage.

Other settlements were reached out of court, with terms typically kept confidential. These settlements and verdicts contributed to a growing body of evidence supporting the connection between Prilosec and kidney disease, further bolstering plaintiff claims in the MDL.

Long-term PPI Use and Bone Fractures

an image of a letter to someone who is not in contact with the person on the phone
an image of a letter to someone who is not in contact with the person on the phone

Another active area of litigation involves the link between long-term Prilosec use and bone fractures. Prolonged PPI use can lead to a decrease in bone density, increasing the risk of debilitating bone fractures.

Lawsuits allege that AstraZeneca and Procter & Gamble were aware of these risks but did not sufficiently warn patients. Instead, they promoted Prilosec for long-term use, encouraging users to take the drug for months or even years despite its questionable long-term safety.

Bank Account, No Response, Accounting
Bank Account, No Response, Accounting
What Exactly Can Be Taken From You In A Lawsuit?
What Exactly Can Be Taken From You In A Lawsuit?
Kraken’s Powell claims in lawsuit he was denied housing due to crypto ties
Kraken’s Powell claims in lawsuit he was denied housing due to crypto ties
Petition Letter
Petition Letter
an official notice from the police department to their employees on how they are doing business
an official notice from the police department to their employees on how they are doing business
Facebook Users, Document Sign
Facebook Users, Document Sign
an advertisement for fed ex with the company's logo and description below it,
an advertisement for fed ex with the company's logo and description below it,
an official letter from the department of justice
an official letter from the department of justice
the official document for the court of justice is shown in this image, and it appears to
the official document for the court of justice is shown in this image, and it appears to

Bellwether Trials and Future Litigation

In 2019, the U.S. District Court for the District of New Jersey consolidated Prilosec bone fracture lawsuits into an MDL. The first bellwether trials in this MDL are scheduled for late 2021, with the aim of testing jury reactions to evidence regarding the fractures caused by long-term PPI use.

Lawyers involved in the MDL anticipate that these trials will provide valuable insights into potential settlements and ultimate resolutions for the many users who suffered bone fractures while taking Prilosec. As new cases continue to be filed, it is clear that litigation surrounding Prilosec's side effects will remain active in the foreseeable future.

Looking Ahead: Changes in the Pharmaceutical Industry

The ongoing Prilosec lawsuits have sparked much-needed dialogue about the transparency of pharmaceutical company practices and the importance of adequate warning labels. As plaintiffs continue to seek justice, their efforts also serve as a catalyst for industry-wide change, encouraging more rigorous safety testing and clearer communication about potential risks associated with prescription medications.

Maintaining open communication with your healthcare provider about any prescription medication and closely monitoring your health status can help minimize risks and ensure timely medical intervention if necessary. With more public awareness and increased scrutiny of the pharmaceutical industry, patients can take a more active role in their healthcare and make well-informed decisions about their treatment options.